The Buprenorphine Treatment for Young Adults Blending Team designed a training package which highlights the findings of the NIDA CTN study that compared longer term versus short-term buprenorphine/naloxone treatment in an outpatient setting. The 3-hour training program examines the prevalence of and treatment admission rates for nonmedical use of opioids among young adults; provides an overview of opioid use among young adults; explores and increases understanding of the results of new research on using buprenorphine to treat opioid addiction in young adults; and describes the implications of these findings for the treatment of opioid addiction in young adults.
To obtain an overview of the Buprenorphine Treatment Blending product, download the brochure.
Blending Product Materials
Bup for Young Adults Blending Team Members
Laura F. McNicholas, M.D., Ph.D. – Philadelphia VAMC
Michael P. Bogenschutz, M.D. - The University of New Mexico
Geetha Subramanian, M.D. - Johns Hopkins University
Shannon Garrett, M.S.W., LGSW - Mountain Manor Treatment Center
Susan Storti, Ph.D., R.N., CARN-AP - Synergy Enterprises, Inc.
NIDA CTN Lead Investigator: George Woody, M.D., University of Pennsylvania
Thomas Freese, Ph.D. – Pacific Southwest ATTC (Chair)
Pamela Waters, M.Ed. - Southern Coast ATTC
Thomas Durham, Ph.D., LDAC - Central East ATTC
Beth Rutkowski, M.P.H. – Pacific Southwest ATTC